Navigation Links
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
Date:12/3/2008

>

Adverse reactions

In chronic phase patients, the most commonly reported adverse reactions (>10%) were rash (33%), pruritus (29%), nausea (31%), fatigue (28%), headache (31%), constipation (21%), diarrhea (22%) and vomiting (21%). The most common (>10%) Grade 3/4 adverse reactions were thrombocytopenia (28%), neutropenia (28%), elevated lipase (15%) and hyperglycemia (11%). In accelerated phase patients, the most commonly reported adverse reactions (>10%) were rash (28%), pruritus (20%) and constipation (18%). The most common (>10%) Grade 3/4 adverse reactions were thrombocytopenia (37%), neutropenia (37%), anemia (23%) and elevated lipase (17%). Other serious adverse reactions included pneumonia, febrile neutropenia, leukopenia, intracranial hemorrhage and pyrexia (Grade 3/4: 2%).

Dose adjustments or modifications

Tasigna may need to be temporarily withheld and/or dose reduced for QT prolongation, hematological toxicities that are not related to underlying leukemia, clinically significant moderate or severe nonhematologic toxicities, laboratory abnormalities, or concomitant use of strong CYP3A4 inhibitors. With concomitant use of strong CYP3A4 inducers, the dose of Tasigna may need to be increased, depending on patient tolerability.

Other patients in whom Tasigna should be used with caution

Tasigna should not be used during pregnancy. Sexually active female patients should use effective contraception during treatment. Women should not breast feed while taking Tasigna. There are no data to support the use of Tasigna in pediatric patients. Use with caution in patients with hepatic impairment.

Please see full Prescribing Information.

About Exjade

Exjade(R) (deferasirox) is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patien
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
4. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
5. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
6. Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. New Conflict of Interest Violations Revealed at California Stem Cell Institute
9. St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia
10. Protein Tomography(TM) Reveals Molecular Mode of Action of Humax-EGFr Published in PNAS
11. Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... --A Harvard medical expert internationally recognized as a ... Tour,s decision last month to suspend Doug Barron ... as having the medical condition hypogonadism ... "unreasonable, unfair and discriminatory." ,, Hypogonadism ... levels, often referred to informally as Low ...
(Date:12/15/2009)... 15 Fenwal Inc., a global medical ... safety and availability, announced today that the U.S. ... to market InterSol ® platelet additive solution. ... is a specialized product used in combination with ... blood component used to prevent or treat bleeding. ...
(Date:12/15/2009)... 15 Reportlinker.com announces that a ... its catalogue: ,, Boehringer Ingelheim GmbH: ... ,, Introduction ,, This analysis ... Boehringer Ingelheim in the Rx pharmaceutical sector. ... pipeline analysis and assessment of financial performance, ...
Breaking Medicine Technology:Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 2Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 3Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 4Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7Marine biomedicine researchers decode structure of promising sea compound 9730 1Marine biomedicine researchers decode structure of promising sea compound 9730 2Childrens Hospital of Pittsburgh of UPMC Recognized for Deepest Use of Electronic Health Records for a Pediatric Hospital in Nation 55631 1Childrens Hospital of Pittsburgh of UPMC Recognized for Deepest Use of Electronic Health Records for a Pediatric Hospital in Nation 55631 2Childrens Hospital of Pittsburgh of UPMC Recognized for Deepest Use of Electronic Health Records for a Pediatric Hospital in Nation 55631 3Scans Shed New Light on Concussions 55629 1Scans Shed New Light on Concussions 55629 2
... and Reported Today ... Study Completed, HAMBURG, Germany and OXFORD, England, March ... to announce the,preliminary findings of a double-blind, single-dose, 3-way ... receptor antagonist, EVT,101. The study was performed in 19 ...
... In the medical,community at large, there is no ... in the heart muscle. Multiple attempts by medical,research scientists ... repair,itself after an individual suffers a heart attack have ... Critical Care Medicine, located in Rancho Mirage,California, is home ...
Other Medicine Technology:Evotec's EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks 2Evotec's EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks 3Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack 2
(Date:12/15/2009)... with lower dementia risk, research finds , , TUESDAY, Dec. ... a hormone that regulates appetite, may guard against Alzheimer,s ... 15 years this may be one of many agents ... disease," said senior study author Dr. Sudha Seshadri, an ... Medicine. "Or it may be one of many markers ...
(Date:12/15/2009)... will train advocates to be leaders in the ... with support from experts in online learning, the ... Dec. 15 ONE and ... applications for the first-ever "Malaria Griots" program, a ... participants to become leaders in the fight against ...
(Date:12/15/2009)... --The following are the remarks by Lanny ... division, at the Medicare Fraud Strike Force press ... you for the enormous effort everyone at HHS ... Together, our Departments have and will continue to ... tremendous progress in fighting Medicare fraud in South ...
(Date:12/15/2009)... Mich. A new study links chronic obstructive pulmonary ... act as sentinels to activate the body,s immune system. ... research adds to growing awareness of the immune system,s ... affects more than 12 million Americans with wheezing, shortness ... factors is key if doctors are to find better ...
(Date:12/15/2009)... still too early to say that phthalates ... Dec. 15 (HealthDay News) -- Common chemicals found ... the abnormal growth of breasts in boys, preliminary ... a prominent medical journal for pediatricians, adds fuel ... whose safety has been questioned by some scientists. ...
Breaking Medicine News(10 mins):Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 2Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 3Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 2Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 3
... in Significantly Lower Infection ... ... about the,rising incidence of methicillin-resistant Staphylococcus aureus (MRSA),infections have prompted lawmakers ... take more aggressive steps to prevent its spread.,Three states have passed ...
... today,at the Society of Interventional Radiology,s 33rd Annual ... metro area, only 18 percent of the,women who ... uterine,fibroid embolization (UFE), a minimally invasive treatment for ... safe, effective,established treatment that has been widely available ...
... 18 NHS Choices ( http://www.nhs.uk ), the,digital ... Autism package aimed to,help people learn more about ... on NHS accredited information, the features (, http://www.nhs.uk/Livewell/Autism/Pages/Autismhome.aspx ... and provides them with clinically approved,guidance to help ...
... Greenhill & Co., Inc.,(NYSE: GHL ), a ... will join the Firm as a Managing Director. Mr.,Giaquinto, ... Health Care,Group at Citigroup Global Markets, will focus on ... spent 18 years covering health care companies as an,investment ...
... white matter levels may assist early identification of walking problems ... age-related changes to white matter in the brain affects how ... their balance, a new study says. , White matter changes ... The study participants included 639 women and men, ages 65 ...
... market will see a compound annual growth, rate of ... Group, WALTHAM, Mass., March 18 According to ... report, which covers markets in the US, Europe, and ... grow from a value,of just under $60 million in ...
Other Medicine News:Health News:More States Move to Require Hospitals to Screen Patients for MRSA 2Health News:More States Move to Require Hospitals to Screen Patients for MRSA 3Health News:More States Move to Require Hospitals to Screen Patients for MRSA 4Health News:Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 2Health News:Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 3Health News:Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 4Health News:Balance in Old Age Tied to Brain Changes 2Health News:Global Cervical Artificial Disc Market to Hit $1 Billion by 2012 2
... higher magnification for advanced surgical procedures. Prismatic ... at the highest magnification. 3.5x, 4.5x and ... color rendition is ideal for surgical applications. ... produce a superior image. The compact abd ...
... The XL Advantage delivers higher magnification ... a crisp, true image, even at the ... to edge clarity and precise color rendition ... treated with an anti-reflective coating produce a ...
... Made up of doublet objective and high ... 2.5x and 3.0x. The true benefit of ... whilst maintaining focal clarity is made possible ... The ultra lightweight aluminum bar and individual ...
... Galilean loupes are ideal for general ... magnification and a large field of ... laser aligned, lightweight and comfortable to ... distance and superior depth of focus ...
Medicine Products: